ARCHIVES

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Parkinson Heads Oncology At Amgen

May 2, 2003

Gerald Murphy To Leave Cancer Society Sept. 1 To Direct Foundation

April 23, 1993

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”

January 7, 1977

ACCC Members To Lobby, Hear Discussion on Oncology Unit

January 6, 1978

Hairy Cell Leukemia Patients Have CRs In Phase I Trial

September 28, 2001